In last trading session, Astria Therapeutics Inc (NASDAQ:ATXS) saw 0.37 million shares changing hands with its beta currently measuring 0.33. Company’s recent per share price
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 0.43. At the close of
In last trading session, Astria Therapeutics Inc (NASDAQ:ATXS) saw 1.4 million shares changing hands with its beta currently measuring 0.45. Company’s recent per share price
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 0.56. At the close of
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 0.66. At the close of
In the latest trading session,, 0.42 million Astria Therapeutics Inc (NASDAQ:ATXS) shares changed hands as the company’s beta touched 0.66. With the company’s most recent
In last trading session, Astria Therapeutics Inc (NASDAQ:ATXS) saw 0.34 million shares changing hands with its beta currently measuring 0.45. Company’s recent per share price
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 0.86 million during the last session, with the company’s beta value hitting 0.60. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
